• LAST PRICE
    10.0200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 10.0200
  • Day Range
    ---
  • 52 Week Range
    Low 9.6600
    High 10.5000
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 10.02
TimeVolumeEBAC
09:55 ET30010.02
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesEBAC
European Biotech Acquisition Corp
164.3M
138.8x
---
United StatesGSQB
G Squared Ascend II Inc
164.4M
35.5x
---
United StatesNRO
Neuberger Berman Real Estate Securities Income Fund Inc
163.7M
0.0x
---
United StatesSCMA
Seaport Calibre Materials Acquisition Corp
164.9M
26.7x
---
United StatesMEOA
Minority Equality Opportunities Acquisition Inc
165.1M
13.3x
---
United StatesWWHC
W World Corp
163.5M
-56.5x
---
As of 2022-12-08

Company Information

European Biotech Acquisition Corp is a blanc check company based in the Netherlands. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company intends to primarily seek to identify a company within the European life sciences industry. The aim of the Company is investments in therapeutic drug candidates in clinical development across a range of therapeutic areas, including oncology, diabetes, cardiology, central nervous system (CNS) and orphan diseases.

Contact Information

Headquarters
Johannes Vermeerplein 9 1071 DvAMSTERDAM, Netherlands 00000
Phone
---
Fax
---

Executives

Chairman of the Board
Martijn Kleijwegt
Chief Executive Officer
Eduardo Bravo Fernandez de Araoz
Chief Financial Officer
Koen Sintnicolaas
Director
Mark Wegter
Independent Director
Volkert Doeksen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$164.3M
Revenue (TTM)
$0.00
Shares Outstanding
16.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$0.07
Book Value
$7.37
P/E Ratio
138.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.